The association of timing of pharmacological prophylaxis and venous thromboembolism in patients with moderate-to-severe traumatic brain injury: A retrospective cohort study
Open Access
- 19 April 2022
- journal article
- research article
- Published by Medknow in Annals of Thoracic Medicine
- Vol. 17 (2), 102-109
- https://doi.org/10.4103/atm.atm_174_21
Abstract
OBJECTIVES: Patients with traumatic brain injury (TBI) have an increased risk for venous thromboembolism (VTE). The current guidelines recommend pharmacologic prophylaxis, but its timing remains unclear. METHODS: In this retrospective cohort study, patients with moderate-to-severe TBI admitted to a tertiary care intensive care unit between 2016 and 2019 were categorized into two groups according to the timing of pharmacologic prophylaxis: early if prophylaxis was given within 72 h from hospital admission and late if after 72 h. RESULTS: Of the 322 patients in the cohort, 46 (14.3%) did not receive pharmacological prophylaxis, mainly due to early brain death; 152 (47.2%) received early pharmacologic prophylaxis and 124 (38.5%) received late prophylaxis. Predictors of late pharmacologic prophylaxis were lower body mass index, intracerebral hemorrhage (odds ratio [OR], 3.361; 95% confidence interval [CI], 1.269–8.904), hemorrhagic contusion (OR, 3.469; 95% CI, 1.039–11.576), and lower platelet count. VTE was diagnosed in 43 patients on a median of 10 days after trauma (Q1, Q3: 5, 15): 6.6% of the early prophylaxis group and 26.6% of the late group (P < 0.001). On multivariable logistic regression analysis, the predictors of VTE were Acute Physiology and Chronic Health Evaluation II score, subarachnoid hemorrhage, and late versus early pharmacologic prophylaxis (OR, 3.858; 95% CI, 1.687–8.825). The late prophylaxis group had higher rate of tracheostomy, longer duration of mechanical ventilation and stay in the hospital, lower discharge Glasgow coma scale, but similar survival, compared with the early group. CONCLUSIONS: Late prophylaxis (>72 h) was associated with higher VTE rate in patients with moderate-to-severe TBI, but not with higher mortality.Keywords
This publication has 34 references indexed in Scilit:
- Safety and Efficacy of Prophylactic Anticoagulation in Patients with Traumatic Brain InjuryJournal of the American College of Surgeons, 2011
- Is Early Venous Thromboembolism Prophylaxis Safe in Trauma Patients With Intracranial HemorrhageThe Journal of Trauma and Acute Care Surgery, 2011
- Early Venous Thromboembolic Event Prophylaxis in Traumatic Brain Injury with Low-Molecular-Weight Heparin: Risks and BenefitsJournal of Neurotrauma, 2010
- Incidence and Risk Factors for Deep Venous Thrombosis After Moderate and Severe Brain InjuryThe Journal of Trauma and Acute Care Surgery, 2010
- Early Venous Thromboembolism Prophylaxis With Enoxaparin in Patients With Blunt Traumatic Brain InjuryThe Journal of Trauma and Acute Care Surgery, 2008
- The Practice of Venous Thromboembolism Prophylaxis in the Major Trauma PatientThe Journal of Trauma and Acute Care Surgery, 2007
- Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseasesThrombosis and Haemostasis, 2004
- Economic Burden of Long-Term Complications of Deep Vein Thrombosis after Total Hip Replacement Surgery in the United StatesValue in Health, 2003
- APACHE IICritical Care Medicine, 1985
- THE INJURY SEVERITY SCOREThe Journal of Trauma and Acute Care Surgery, 1974